Underlying disorders associated with severe early-onset preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 173, Issue 4, 1995, Pages 1042-1048

  Dekker, G A ^a   de Vries, J I P ^a   Doelitzsch, P M ^a   Huijgens, P C ^a   von Blomberg, B M E ^a   Jakobs, C ^a   van Geijn, H P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

activated protein C resistance; anticardiolipin antibodies; chronic hypertension; hyperhomocysteinemia; Preeclampsia; protein S deficiency

Indexed keywords

ANTITHROMBIN III; CARDIOLIPIN ANTIBODY; HOMOCYSTEINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S;

ADULT; AMINO ACID BLOOD LEVEL; ANTIBODY BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL DISEASE; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RISK FACTOR; SCREENING TEST;

ANTIBODIES, ANTICARDIOLIPIN; ANTITHROMBIN III DEFICIENCY; FEMALE; HOMOCYSTEINE; HUMAN; HYPERTENSION; PRE-ECLAMPSIA; PREGNANCY; PROTEIN C; PROTEIN S DEFICIENCY; THROMBOSIS;

EID: 0028802731     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9378(95)91324-6     Document Type: Article

References (27)

1. The second international anti-cardiolipin standardization workshop/the Kingston Antiphospholipid Antibody Study (KAPS) group
2. The natural history of homocysteinuria due to cystathionine-synthase deficiency
3. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum
4. 6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia
5. Protein C: comparison of different assays in normal and abnormal plasma samples
6. The simultaneous measurement of total and free protein S by ELISA
7. Laboratory diagnosis of antithrombin and heparin cofactor II deficiency
8. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
9. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
10. Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients
11. Association of a novel high oxygen affinity haemoglobin variant with δβ thalassaemia
12. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis: Leiden Thrombophilia Study
13. Absence of thrombosis in subjects with heterozygous protein C deficiency
14. Prevalence of antithrombin deficiency in the healthy population
15. Recurrent fetal loss and the antiphospholipid syndrome
16. The role of antiphospholipid antibodies in obstetric medicine
17. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects
18. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss
19. Tumor necrosis factor-alpha downregulates protein S secretion in human microvascular and umbilical vein endothelial cells but not in the HepG-2 hepatoma cell line
20. Enhanced thrombin generation in normal and hypertensive pregnancy
21. Mutation in blood coagulation factor V associated with resistance to activated protein C
22. Interlaboratory variation in antiphospholipid antibodies testing
23. Hyperhomocysteinemia: an independent risk fctor for vascular disease
24. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease
25. Heterozygosity for homocysteinuria in premature peripheral and cerebral occlusive arterial disease
26. Intrauterine growth retardation, perinatal death, and maternal homocysteine levels
27. Hyperhomocysteinemia and recurrent abortion or abruptio placentae